Minimally invasive subclavian/axillary artery to coronary artery bypass (SAXCAB): review and classification

A S Coulson1, E F Glasgow, J Bonatti

  • 1Dameron Heart Institute, Stockton, CA, USA.

The Heart Surgery Forum
|August 15, 2001
PubMed

Insights

Subclavian/axillary artery to coronary artery bypass (SAXCAB) surgery offers a unique, minimally invasive approach to coronary revascularization. This technique demonstrates significant graft patency and a favorable safety profile, making it a noteworthy alternative in cardiac surgery.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Vascular Anatomy

Background:

  • Subclavian/axillary artery to coronary artery bypass (SAXCAB) surgery is a minimally invasive coronary revascularization technique.
  • It involves anastomosing grafts to the subclavian or axillary arteries and coronary arteries through separate small incisions.
  • Understanding chest wall and vascular anatomy is crucial for SAXCAB procedures.

Purpose of the Study:

  • To review the indications, contraindications, and relevant anatomy for SAXCAB surgery.
  • To classify the diverse variations of SAXCAB grafting techniques.
  • To discuss future research directions for SAXCAB surgery.

Main Methods:

  • Telephone and mail inquiries to surgeons who published SAXCAB techniques in 2000.
  • Informal personal communications to gather data on case numbers and outcomes.
  • Analysis of published data to assess the international status of the procedure.

Main Results:

  • Estimated international experience of approximately 100 SAXCAB cases.
  • Graft patency rates reported between 70% and 100% at one to two years.
  • SAXCAB surgery appears to be a very safe operation with no reported major complications.

Conclusions:

  • SAXCAB surgery is a unique and interesting class within minimally invasive direct coronary artery bypass (MIDCAB) surgery.
  • The diversity of SAXCAB techniques requires comprehensive knowledge for surgical application and potential rescue operations.
  • SAXCAB offers a safe alternative for coronary revascularization, with potential for tailored patient-specific approaches.
Abstract